Arcinova is an agile Contract Development & Manufacturing Organisation (CDMO), providing the pharmaceutical industry with a full suite of drug substance, drug product and analytical support services from preclinical through to small scale commercial.

From our world-class 15,000m2 facility (ex-Sanofi, Covance), we offer process, research, development, scale-up and small scale manufacturing, including bioanalysis, regulatory and consulting services. We also have niche expertise in radiolabelling, providing 14C radiolabelled material for non-clinical and clinical needs.

Our large company track record and compliance coupled with the responsiveness and agility of a smaller company allows us to deliver high quality end-to-end solutions in a timely and cost-effective manner.

Our mission at Arcinova is to deliver best-in-class technology services in the fields of contract research, development and small scale manufacturing whilst minimising risk and overall cost.

LinkedIn logo Senior Director of Business Development, Europe 
LinkedIn logo Snr Director, Business Development 

UK Department for International Trade

A number of companies shown here with profiles and logos are financially supported by the UK government's Tradeshow Access Programme.

Achilles Therapeutics

Achilles Therapeutics is a biopharmaceutical company developing novel cancer immunotherapies targeting clonal neoantigens: protein markers unique to each individual that are expressed on the surface of every cancer cell. Achilles uses DNA sequencing data from each patient, together with a proprietary bioinformatics platform, to identify clonal neoantigens specific to that patient and enable the development of personalised cell therapies. Targeting multiple clonal neoantigens that are present on all cancer cells, but not on healthy cells, allows individualised treatments to target and destroy tumours without harming healthy tissues.

Company Type
Dara Henry
LinkedIn logo VP Business Development 
Beverley Carr
LinkedIn logo CBO 

Albumedix Ltd

Albumedix is an integrated biotech company with a strong pipeline of  albumin-enabled therapeutics developed by partners (incl. CSL Behring, Merck & GSK) utilizing our innovative albumin-based, drug enhancing products and technologies.

Company Type
Jonas Moller
LinkedIn logo Chief Executive Officer 
Gary Willingham
LinkedIn logo Business Development Director 
Harriet Edwards
LinkedIn logo Director, Regulatory Affairs 

Arctoris Ltd

Arctoris Ltd is an Oxford-based startup revolutionising cancer research by combining robotics & AI. Arctoris enables researchers to configure their experiments remotely and have them executed in a fully automated cloud laboratory.

Company Type
Martin-Immanuel Bittner
LinkedIn logo Co-Founder & CEO 

BioPartner United Kingdom

BioPartner UK leads the UK Delegation to several partnering conferences each year. It is a UK Accredited Trade Organisation facilitating international partnering for trade, investment and collaborations with Life Sciences organisations across the UK. BioPartner is a membership organisation, supporting UK SMEs and startups, and signposting organisations worldwide to UK expertise.

BioPartner has alliances with organisers of international biopartnering events, and with UK membership organisations, operating both independently and in partnership with the UK government. BioPartner disseminates tradeshow access grants to help UK-based SMEs exhibit their services and products in new overseas markets.

Dr William Watson
LinkedIn logo Advisory Board 


CytoSeek is engaged in proof of principle studies to demonstrate enhancement of cell therapies for cancer, heart disease, osteoarthritis and diabetic wound healing. We are looking to partner with cell therapy companies to bring these products to the clinic and ultimately enhance human health.

Company Type
Carolyn Porter
LinkedIn logo CEO 

Enesi Pharma Limited

Enesi Pharma is an early stage pharmaceutical company developing innovative needle-free solid dose vaccine products with potential to transform performance and delivery of vaccines and make a material impact on global healthcare.

Company Type
David Hipkiss
LinkedIn logo Chief Executive Officer 


We connect industry with the latest research from universities from around the world.

Company Type
Seren Kell
LinkedIn logo Business Development Manager 

Intract Pharma

Intract Pharma Limited is an oral drug delivery licensing and product development company offering a range of proprietary formulation technologies to deliver novel and optimised therapeutics targeted to patient needs. The company is a spin-out of University College London, and is centred around over 15 years of research and innovation from the laboratory of Professor Abdul Basit. Intract's range of formulation technologies includes Phloral™ for colon targeted delivery, and ProRelease™, a versatile microparticulate delivery system.

Company Type
Mr Bill Lindsay
LinkedIn logo CEO